Endoscopic vein harvesting
- PMID: 33841978
- PMCID: PMC8024854
- DOI: 10.21037/jtd-20-1819
Endoscopic vein harvesting
Abstract
Coronary artery bypass grafting is the most common cardiac surgical procedure performed worldwide and the long saphenous vein the most common conduit for this. When performed as an open vein harvest (OVH), the incision on each leg can be up to 85cm long, making it the longest incision of any routine procedure. This confers a high degree of morbidity to the procedure. Endoscopic vein harvest (EVH) methods were popularised over two decades ago, demonstrating significant benefits over OVH in terms of leg wound complications including surgical site infections. They also appeared to hasten return to usual activities and wound healing and became popular particularly in North America. Subgroup analyses of two trials designed for other purposes created a period of uncertainty between 2009-2013 while the impact of endoscopic vein harvesting on vein graft patency and major adverse cardiac events was scrutinised. Large observational studies debunked the findings of increased mortality in the short-term, allowing practitioners and governing bodies to regain some confidence in the procedure. A well designed, adequately powered, randomised controlled trial published in 2019 also definitively demonstrated that there was no increase in death, myocardial infarction or repeat revascularisation with endoscopic vein harvest. Endoscopic vein harvest is a Class IIa indication in European Association of Cardio-Thoracic Surgery (EACTS) and a Class I indication in International Society of Minimally Invasive Cardiac Surgery (ISMICS) guidelines.
Keywords: Coronary artery bypass; conduit; endoscopic; minimally invasive; saphenous vein.
2021 Journal of Thoracic Disease. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jtd-20-1819). The series “Minimally Invasive Cardiac Surgery” was commissioned by the editorial office without any funding or sponsorship. JZ reports proctoring and speaking fees from Edwards Lifesciences, Cryolife, and Abbott, and funded a clinical fellow post for 12 months from LSI solutions. The other authors have no conflicts of interest to declare.
Figures
References
-
- Mason PJ, Shah B, Tamis-Holland JE, et al. An Update on Radial Artery Access and Best Practices for Transradial Coronary Angiography and Intervention in Acute Coronary Syndrome: A Scientific Statement From the American Heart Association. Circ Cardiovasc Interv 2018;11:e000035. 10.1161/HCV.0000000000000035 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources